Skip to main content
All

Arnold & Porter Elects Eight Partners And Three Counsel For 2007

January 16, 2007

Washington, D.C., January 16, 2007 - The international law firm of Arnold & Porter LLP has elected eight new partners and three counsel.  The expertise represented by the group includes litigation, pharmaceutical, food and medical technology, corporate and securities, antitrust/competition and trade regulation, white collar defense, intellectual property and technology and consumer protection.  All positions were effective January 1, 2007.  Six new partners are resident in the Washington, D.C. office and one each in New York and London.  Two new counsel are resident in the Northern Virginia office and one in Washington, D.C.

Former counsel who have been elected partner are:

Evelina J. Norwinski, a member of the litigation and white collar defense practice groups.  Ms. Norwinski received her law degree from Stanford Law School and is resident in the firm's Washington, D.C. office.  She has represented corporations and individuals in a broad range of criminal and civil matters in both federal and state courts, including cases involving RICO, Lanham Act, product liability, environmental liability and Americans with Disabilities Act.  She has argued more than 20 appeals in the U.S. Courts of Appeal and assisted clients on various corporate policy matters and internal investigations.

Ali R. Sharifahmadian, a member of the intellectual property group and resident in the firm's Washington, D.C. office.  Mr. Sharifahmadian received his law degree from William and Mary School of Law.  His practice focuses on intellectual property litigation at both the trial and appellate levels, including patent, trade secret and unfair competition litigation in the computer, software and electronics technologies.  Mr. Sharifahmadian also has extensive experienced counseling clients on licensing issues, prosecuting patent applications, and providing opinions on issues such as infringement, validity and enforceability.  Mr. Sharifahmadian is registered to practice before the U.S. Patent & Trademark Office.

Dr. Lincoln Tsang, a member of the pharmaceutical, food and medical technology practice group and a recognized authority in the biotechnology regulatory field.  He is resident in the firm's London office.  Dr. Tsang received his law degree from the University of London and his doctorate in biochemical toxicology from the University of Aston in Birmingham.  His practice relates to life sciences industry including pharmaceuticals, biotechnology, medical devices, cosmetics and food.  He advises foreign governments, various trade associations and not-for-profit and/or charity organizations on biotechnology, pharmaceuticals and devices regulation.

Former associates who have been elected partner are:

Anne P. Davis, a member of the litigation group and resident in the firm's Washington, D.C. office.  Ms. Davis received her law degree from the University of Virginia School of Law, where she was an editor of the Virginia Law Review.  Ms. Davis has represented clients in a variety of civil and criminal matters including state and federal antitrust litigation, blood banking litigation, shareholder derivative suits and class actions, SEC and Department of Justice securities and accounting fraud investigations, as well as pro bono immigration, criminal and voting rights matters.  In 2003-2004, during a leave from the firm, Ms. Davis served as a prosecuting trial attorney at the United Nations' International Criminal Tribunal for the former Yugoslavia in the Hague, the Netherlands.

Lily J. Lu, a member of the corporate and securities practice group.  She received her law degree from Columbia Law School and is resident in the firm's New York office.  Ms. Lu has extensive experience in all types of corporate and securities transactions, including mergers and acquisitions, private and public securities offerings and lending transactions.  In addition, she has advised domestic and foreign clients with respect to corporate governance issues and Securities and Exchange Commission compliance matters.

Wilson D. Mudge, a member of the antitrust/competition and trade regulation and litigation practice groups.  He received his law degree from American University, Washington College of Law, and is resident in the firm's Washington, D.C. office.  Mr. Mudge's antitrust practice encompasses transactional matters, civil litigation, government civil and criminal investigations and counseling.  He has represented clients in a wide variety of sectors, including semiconductors, software and pharmaceuticals, as well as organic and inorganic chemicals, among others.

Mara V.J. Senn, a member of the litigation practice group and is resident in the firm's Washington, D.C. office.  She received her law degree from New York University School of Law.  Ms. Senn has had extensive trial experience.  Her practice has concentrated in securities, white collar and international law.  She has represented a diverse range of governmental and commercial clients in litigation, internal investigations and international arbitration. 

James W. Thomas, Jr., a member of the litigation practice group and resident in the firm's Washington, D.C. office.  He received his law degree from George Washington University.  Mr. Thomas's practice has focused on complex commercial litigation in the areas of securities fraud and shareholder derivative litigation and representation of clients before government agencies.  His experience includes representing public corporations, accounting firms, and members of management and boards of directors, in general civil litigation, securities fraud and shareholder derivative litigation, and in connection with regulatory, investigative and enforcement matters instituted by government agencies.

Former associates who have been elected counsel are:

David G. Dargatis, a member of the corporate and securities practice group.  He received his law degree from the University of Iowa College of Law and is resident in the firm's Northern Virginia office.  Mr. Dargatis has a diverse corporate transactional and counseling practice, which encompasses an array of sophisticated domestic and international business transactions and matters, including mergers and acquisitions, private equity investment and fund formation, venture capital investment and various other corporate transactional and counseling matters.  Although his clients operate in numerous industries and sectors, Mr. Dargatis has special expertise in representing private companies, as well as public companies in private transactions and matters.

Amy Ralph Mudge, a member of the antitrust/competition and trade regulation and consumer protection practice groups.  She received her law degree from Cornell Law School and is resident in the firm's Washington, D.C. office.  Ms. Mudge has represented clients in a wide variety of industries, including cigarettes, agriculture, Internet services, pharmaceuticals, dietary supplements and car rentals.  She has represented clients before the Federal Trade Commission, Department of Justice, state attorneys general, and the self-regulatory National Advertising Division, as well as in private federal and state litigation.

David A. Rhodes, a member of the intellectual property and technology group and resident in the firm's Northern Virginia office.  He received his law degree from Tulane Law School.  Mr. Rhodes' practice focuses principally on complex commercial and technology transactions.  He has experience drafting and negotiating a broad variety of contracts for the commercialization of intellectual property and technology development agreements, outsourcing agreements, marketing and distribution arrangements and manufacturing agreements.

Arnold & Porter LLP, an international law firm of more than 600 attorneys, has offices in Washington, D.C., Northern Virginia, New York, Los Angeles, San Francisco, Denver, London and Brussels.  The firm, founded in 1946, maintains more than 25 practice areas spanning a broad spectrum of the law, with a primary focus on litigation, transactional matters and regulatory issues.